Document is current
Any future updates will be listed below
-
Authors
Wan, Eric Yuk Fai
Yu, Esther Yee Tak
Chin, Weng Yee
Lau, Christie Sze Ting
Mok, Anna Hoi Ying
Wang, Yuan
Wong, Ian Chi Kei
Chan, Esther Wai Yin
Lam, Cindy Lo Kuen
-
Funding
Funding for this research was provided by:
The Health Services Research Fund, Food and Health Bureau, HKSAR (Ref. no 14151181)
- License Information
-
More Information
Article History
Received: 7 August 2020
Accepted: 5 March 2021
First Online: 13 April 2021
Competing interests
: I.C.K.W. received funding from Pfizer, Bayer and Novartis to evaluate real world evidence on pharmacological treatments of cardiovascular diseases but not related to current study. E.W.Y.C. received research grants from Bayer, Bristol-Myers Squibb, Janssen, a Division of Johnson and Johnson, Pfizer, and Takeda to evaluate real world evidence on pharmacological treatments of cardiovascular diseases but not related to current study. Other authors declare that they have no competing interests.
